However, no changes in Akt, p-Akt, mTOR, or p-mTOR were observed following cholesterol lowering gene therapy in sham mice, indicating that isolated mild hypercholesterolemia in control sham mice is not sufficient to induce these alterations. This evidence concerns the gene MTOR and Hypercholesterolemia.